Detailed view for Tb11.v5.0531

Basic information

TDR Targets ID: 20021
Trypanosoma brucei, fructose-bisphosphate aldolase, glycosomal, putative

Source Database / ID:  TriTrypDB  GeneDB

pI: 8.9434 | Length (AA): 372 | MW (Da): 41071 | Paralog Number: 0

Signal peptide: N | GPI Anchor: | Predicted trans-membrane segments: 0

Druggability Group : DG4

Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable

Pfam domains

PF00274   Fructose-bisphosphate aldolase class-I

Gene Ontology

Mouse over links to read term descriptions.
GO:0004332   fructose-bisphosphate aldolase activity  
GO:0003824   catalytic activity  
GO:0008152   metabolic process  
GO:0006096   glycolysis  

Structural information

Modbase 3D models:

There is 1 model calculated for this protein. More info on this model, including the model itself is available at: Modbase

Target Beg Target End Template Template Beg Template End Identity Evalue Model Score MPQS zDope
2 358 1f2j (A) 1 357 99.00 0 1 2.20138 -1.61

Help me make sense of these data.

Target Beg: first modeled residue
Target End: last modeled residue
Template: template structure used for modelling (PDB accession and chain)
Template Beg: first template residue in target-template alignment
Template End: last template residue in target-template alignment
Identity: sequence identity
Evalue: E value for target-template hit
Model Score: GA341 score (>0.7 for reliable model)
MPQS: ModPipe Quality Score (>1.1 for reliable model)
zDope: zDope Score (negative for reliable model)

A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.

PDB Structures:

  • 1F2J:
  • Resolution Method # Atoms # Residues Dep. Date Pub. Date Mod. Date

Expression

Upregulation Percent Ranking Stage Dataset
NA% percentile Procyclic. Siegel TN
Upregulation Percent Ranking Stage Dataset
Lower 20-40% percentile Bloodstream Form. Siegel TN
Show/Hide expression data references
  • Siegel TN Genome-wide analysis of mRNA abundance in two life-cycle stages of Trypanosoma brucei and identification of splicing and polyadenylation sites.

Orthologs

Ortholog group members (OG5_127143)

Species Accession Gene Product
Arabidopsis thaliana AT2G01140   fructose-bisphosphate aldolase 3
Arabidopsis thaliana AT4G26520   fructose-bisphosphate aldolase 7
Arabidopsis thaliana AT4G38970   fructose-bisphosphate aldolase 2
Arabidopsis thaliana AT5G03690   fructose-bisphosphate aldolase 4
Arabidopsis thaliana AT2G36460   fructose-bisphosphate aldolase 6
Arabidopsis thaliana AT3G52930   fructose-bisphosphate aldolase
Arabidopsis thaliana AT4G26530   fructose-bisphosphate aldolase 5
Babesia bovis BBOV_IV000790   fructose-1,6-bisphosphate aldolase
Brugia malayi Bm1_15350   fructose-bisphosphate aldolase 1
Brugia malayi Bm1_09045   fructose-bisphosphate aldolase 2
Caenorhabditis elegans CELE_F01F1.12   Protein ALDO-2, isoform B
Caenorhabditis elegans CELE_T05D4.1   Protein ALDO-1
Cryptosporidium hominis Chro.10335   fructose-1,6-bisphosphate aldolase
Cryptosporidium parvum cgd1_3020   fructose-1,6-bisphosphate aldolase
Dictyostelium discoideum DDB_G0274375   fructose 1,6-bisphosphate aldolase
Drosophila melanogaster Dmel_CG6058   Aldolase
Echinococcus granulosus EgrG_000905600   fructose 16 bisphosphate aldolase
Echinococcus granulosus EgrG_000980100   fructose 16 bisphosphate aldolase
Echinococcus granulosus EgrG_000993700   fructose bisphosphate aldolase class I
Echinococcus granulosus EgrG_000993800   fructose 16 bisphosphate aldolase
Echinococcus multilocularis EmuJ_000993800   fructose 1,6 bisphosphate aldolase
Echinococcus multilocularis EmuJ_000993700   fructose bisphosphate aldolase class I
Echinococcus multilocularis EmuJ_000980100   fructose 1,6 bisphosphate aldolase
Echinococcus multilocularis EmuJ_000905600   fructose 1,6 bisphosphate aldolase
Homo sapiens ENSG00000109107   aldolase C, fructose-bisphosphate
Homo sapiens ENSG00000136872   aldolase B, fructose-bisphosphate
Homo sapiens ENSG00000149925   aldolase A, fructose-bisphosphate
Homo sapiens 102723572   uncharacterized protein LOC102723572
Leishmania braziliensis LbrM.35.1390   fructose-1,6-bisphosphate aldolase
Leishmania donovani LdBPK_361320.1   fructose-1,6-bisphosphate aldolase
Leishmania infantum LinJ.36.1320   fructose-1,6-bisphosphate aldolase
Leishmania major LmjF.36.1260   fructose-1,6-bisphosphate aldolase
Leishmania mexicana LmxM.36.1260   fructose-1,6-bisphosphate aldolase
Loa Loa (eye worm) LOAG_03230   fructose-bisphosphate aldolase 1
Loa Loa (eye worm) LOAG_04016   fructose-bisphosphate aldolase 2
Mus musculus ENSMUSG00000063129   aldolase 1 A, retrogene 2
Mus musculus ENSMUSG00000028307   aldolase B, fructose-bisphosphate
Mus musculus ENSMUSG00000030695   aldolase A, fructose-bisphosphate
Mus musculus ENSMUSG00000017390   aldolase C, fructose-bisphosphate
Mus musculus ENSMUSG00000059343   aldolase 1 A, retrogene 1
Neospora caninum NCLIV_050380   Fructose-bisphosphate aldolase (EC 4.1.2.13), related
Oryza sativa 4341496   Os06g0608700
Oryza sativa 4349897   Os11g0171300
Oryza sativa 4325027   Os01g0905800
Oryza sativa 4326074   Os01g0118000
Oryza sativa 4344545   Os08g0120600
Plasmodium berghei PBANKA_1308600   fructose-bisphosphate aldolase 2
Plasmodium falciparum PF3D7_1444800   fructose-bisphosphate aldolase
Plasmodium knowlesi PKNH_1237500   fructose-bisphosphate aldolase, putative
Plasmodium vivax PVX_118255   fructose 1,6-bisphosphate aldolase, putative
Plasmodium yoelii PY03709   Fructose-bisphosphate aldolase class-I
Schistosoma japonicum Sjp_0031630   ko:K01623 fructose-bisphosphate aldolase, class I [EC4.1.2.13A], putative
Schistosoma mansoni Smp_042160.1   fructose 16-bisphosphate aldolase
Schistosoma mansoni Smp_042160.2   fructose 16-bisphosphate aldolase
Schmidtea mediterranea mk4.015952.00   Fructose-bisphosphate aldolase
Schmidtea mediterranea mk4.030385.00  
Schmidtea mediterranea mk4.002266.03  
Schmidtea mediterranea mk4.014110.00  
Schmidtea mediterranea mk4.059262.00  
Trypanosoma brucei gambiense Tbg972.10.6830   fructose-bisphosphate aldolase, glycosomal putative
Trypanosoma brucei Tb11.v5.0531   fructose-bisphosphate aldolase, glycosomal, putative
Trypanosoma congolense TcIL3000_10_4760   fructose-bisphosphate aldolase, glycosomal, putative
Trypanosoma cruzi TcCLB.510301.10   fructose-bisphosphate aldolase, glycosomal, putative
Trypanosoma cruzi TcCLB.504163.40   fructose-bisphosphate aldolase, glycosomal, putative
Trypanosoma cruzi TcCLB.510301.20   fructose-bisphosphate aldolase, glycosomal, putative
Trypanosoma cruzi TcCLB.504163.50   fructose-bisphosphate aldolase, glycosomal, putative
Toxoplasma gondii TGME49_236040   fructose-1,6-bisphosphate aldolase
Toxoplasma gondii TGME49_321900   fructose-1,6-bisphosphate aldolase
Toxoplasma gondii TGME49_236050   fructose-bisphosphate aldolase, putative
Theileria parva TP01_0101   fructose-bisphosphate aldolase, putative

Essentiality

Tb11.v5.0531 has direct evidence of essentiality
Gene/Ortholog Organism Phenotype Source Study
Tb927.10.5620 this record Trypanosoma brucei significant loss of fitness in bloodstream forms (3 days) alsford
Tb927.10.5620 this record Trypanosoma brucei significant loss of fitness in bloodstream forms (6 days) alsford
Tb927.10.5620 this record Trypanosoma brucei significant loss of fitness in procyclic forms alsford
Tb927.10.5620 this record Trypanosoma brucei significant loss of fitness in differentiation of procyclic to bloodstream forms alsford
CELE_F01F1.12 Caenorhabditis elegans embryonic lethal wormbase
CELE_F01F1.12 Caenorhabditis elegans slow growth wormbase
PBANKA_1308600 Plasmodium berghei Essential plasmo
TGME49_236040 Toxoplasma gondii Probably essential sidik
TGME49_236050 Toxoplasma gondii Probably essential sidik
TGME49_321900 Toxoplasma gondii Probably essential sidik
TGME49_236040 Toxoplasma gondii Essentiality uncertain sidik
TGME49_236050 Toxoplasma gondii Essentiality uncertain sidik
TGME49_321900 Toxoplasma gondii Essentiality uncertain sidik
Show/Hide essentiality data references
  • sidik A Genome-wide CRISPR Screen in Toxoplasma Identifies Essential Apicomplexan Genes. Sidik, Saima M., et al. "A genome-wide CRISPR screen in toxoplasma identifies essential apicomplexan genes." Cell 166.6 (2016): 1423-1435.
  • blattner Systematic mutagenesis of the E. coli (MG1655) genome J Bacteriol 2004, 186:4921-4930
  • wormbase C. elegans RNAi experiments WormBase web site, http://www.wormbase.org, release WS170
  • plasmo Functional Profiling of a Plasmodium Genome Reveals an Abundance of Essential Genes. Bushell, Ellen, et al. "Functional profiling of a Plasmodium genome reveals an abundance of essential genes." Cell 170.2 (2017): 260-272.
  • neb C. elegans RNAi phenotypes Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs
  • keio Systematic single-gene knock-out mutants of E. coli K12 The Keio Collection
  • goodall The Essential Genome of Escherichia coli K-12 (Transposon directed high-throughput mutagenesis) Goodall, Emily CA, et al. "The essential genome of Escherichia coli K-12." mBio 9.1 (2018): e02096-17.
  • gerdes Experimental determination and system-level analysis of essential genes in E. coli MG1655 Gerdes et al., J Bacteriol. 2003 185:5673-84
  • alsford High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome Genome Res 2011, 21:915-924
  • nmpdr Genome-scale essentiality datasets from published studies (M. tuberculosis) National Microbial Pathogen Data Resource
  • shigen Profiling of E. coli Chromosome (PEC) National Institute of Genetics, Japan
  • yeastgenome Systematic deletion of yeast genes Saccharomyces Genome Database

Phenotypes and Validation (curated)

Annotated phenotypes:

Affected Entity Phenotypic quality Occurs in Occurs at Evidence Observed in Drugs/Inhibitors
growth (GO:0040007) lethal (sensu genetics) (PATO:0000718) single cell organism (CARO:0000064) bloodstream stage (PLO:0040) inferred from bioassay (ECO:0000094) Trypanosoma brucei brucei No drug identifiers listed for this gene.
Annotator: ts4@sanger.ac.uk. Comment: Drug: 2-hydroxybenzaldehyde-5-phosphate. . References: 16632348
cell proliferation (GO:0008283) decreased (PATO:0000468) bloodstream stage trypomastigotes (PLO:0027) inferred from RNAi experiment (ECO:0000019) No drug identifiers listed for this gene.
Annotator: fernan@iib.unsam.edu.ar. Comment: decreased cell proliferation (significant loss of fitness) in bloodstream forms (stage 6 days). References: 21363968
cell proliferation (GO:0008283) decreased (PATO:0000468) procyclic (PLO:0034) inferred from RNAi experiment (ECO:0000019) No drug identifiers listed for this gene.
Annotator: fernan@iib.unsam.edu.ar. Comment: decreased cell proliferation (significant loss of fitness) in differentiation of procyclic to bloodstream forms . References: 21363968

In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.

In any case, if you have information about papers containing relevant validation data for this target, please contact us.


Annotated validation

  • Validation: inhibited in cell-free system. As observed in: T. b. brucei.Evidence: inferred from specific protein inhibition
  • annotated by: ts4@sanger.ac.uk.
  • References: 16509566
  • Validation: inhibited in cell-free system. As observed in: T. b. brucei.Evidence: inferred from specific protein inhibition
  • annotated by: ts4@sanger.ac.uk.
  • References: 9111046

Associated compounds / Druggability

Known modulators for this target

Compound Source Reference
ChEMBL23 References
Curated by TDRTargets References
Curated by TDRTargets References
Curated by TDRTargets References
Curated by TDRTargets References
Curated by TDRTargets References
Curated by TDRTargets References
Curated by TDRTargets References
Curated by TDRTargets References
Curated by TDRTargets References
Curated by TDRTargets References
Curated by TDRTargets References
Curated by TDRTargets References
Curated by TDRTargets References
Curated by TDRTargets References
Curated by TDRTargets References
Curated by TDRTargets References
Curated by TDRTargets References
Curated by TDRTargets References
Curated by TDRTargets References
ChEMBL23 References
ChEMBL23 References
ChEMBL23 References

Predicted associations

By orthology with druggable targets
Species Known druggable target Linked compounds Reference
Leishmania major fructose-1,6-bisphosphate aldolase Compounds References
Oryctolagus cuniculus Fructose-bisphosphate aldolase A Compounds References
Plasmodium falciparum fructose-bisphosphate aldolase Compounds References
Trypanosoma brucei gambiense fructose-bisphosphate aldolase, glycosomal putative Compounds References
By sequence similarity to non orthologous druggable targets
No additional associated druggable targets

Obtained from network model

Ranking Plot


Putative Drugs List


Compound Raw Global Species
0.0095 0.2859 0.3138
0.011 0.2504 1
0.0207 0.8885 1
0.0174 0.6572 1
0.0579 0.5455 1
0.0095 0.4401 1
0.0272 0.7808 0.9414
0.0084 0.2526 0.8798
0.0095 0.2725 0.2897
0.0263 0.3465 0.372
0.0089 0.253 1
0.0095 0.2605 0.287
0.0618 0.3531 0.8169
0.0281 0.9258 1
0.0097 0.4904 1
0.0096 0.2514 1
0.0088 0.5546 0.5
0.0095 0.279 0.3065
0.0092 0.9066 0.8855
0.009 0.295 0.3234
0.0268 0.9266 1
0.01 0.7614 1
0.0263 0.3465 0.372
0.0543 0.2635 0.5786
0.0272 0.8815 0.8789
0.0587 0.4401 1
0.01 0.3297 1
0.0099 0.2811 0.3087
0.0089 0.3058 0.336
0.0095 0.2859 0.3138
0.0422091 0.46257 1
0.0106 0.5461 0.5
0.009 0.2726 1
0.0294 0.5332 1
0.0093 0.2892 0.3173
0.0323 0.9266 1
0.0293 0.9266 1
0.0062 0.2769 1
0.0272 0.8815 0.8789
0.062 0.3196 0.7399
0.0275 0.3191 1
0.0091 0.5 0.5
0.0091 0.2766 0.304
0.0106 0.535 0.5
0.0304 0.5918 1
0.0566 0.3169 0.749
0.0554 0.3312 0.7687
0.0288 0.926 1
0.0097 0.5082 0.5
0.0088 0.8089 1
0.0272 0.8815 0.8789
0.011 0.2509 1
0.0272 0.7808 0.9414
0.0083 0.418 0
0.0563 1 1
0.0317 0.3736 1
0.0566 0.3169 0.749
0.0089 1 1
0.0268 0.3647 1
0.0297 0.9238 1
0.011 0.286 0.3947
0.0291 0.9258 1
0.0415307 1 1
0.0201929 0.669447 1
0.0088 0.3135 1
0.0298 0.9263 1
0.0099 0.2714 0.954
0.0101 0.3106 1
0.009 0.2726 1
0.0159 0.4544 1
0.0601 0.3502 0.8193
0.0275 0.3191 1
0.0077 1 1
0.011 1 1
0.0099 0.2775 0.9554
0.0317 0.3736 1
0.0197 0.2977 0.9592
0.009 0.5 0.5
0.009 1 0.5
0.0179 0.2552 1
0.0176 0.2504 1
0.0292 0.9258 1
0.0601 0.3502 0.8193
0.0553 1 1
0.0095 0.2826 0.3103
0.009 0.2726 1
0.0098 0.2953 0.3234
0.0095 0.2948 0.3089
0.083 1 1
0.0145 0.4635 1
0.0095 0.279 0.3065
0.0566 0.2737 0.6368
0.0096 0.2573 1
0.0093 0.2509 1
0.011 0.2828 0.9565
0.0095 0.2859 0.3138
0.011 0.2509 1
0.0089 0.3058 0.336
0.0273 0.9258 1
0.0159 0.4544 1
0.0091 0.279 0.9183
0.0323 0.9266 1
0.0579 0.5455 1
0.0116 0.4714 1
0.0120412 0.667736 0.903786
0.0208 0.2932 1
0.0099 0.2811 0.3087
0.011 1 1
0.0095 0.2725 0.2897
0.0088 0.2565 0.3039
0.0104357 0.404212 0.5055
0.0109 0.2509 0.6503
0.0095 0.2812 0.3088
0.0842 1 1
0.0174 0.6123 1
0.0566 0.3169 0.749
0.011 0.2509 1
0.0101 0.3106 1
0.0097 0.4856 0.5
0.0317 0.3736 1
0.0288 0.926 1
0.0098 0.2779 1
0.0323 0.9266 1
0.011 0.2779 1
0.0273 0.9266 1
0.0284 0.3526 1
0.0618 0.3531 0.8169
0.0269 0.6375 1
0.0579 0.5455 1
0.0085 0.2621 0.4574
0.0532 1 1
0.0095 0.2724 0.2816

Assayability

Assay information

  • Assay for Aldolase (4.1.2.13 ) Sigma-Aldrich
  • Automatic link to known assays based on EC numbers.
  • Inhibitory activity against mutated recombinant Trypanosoma brucei aldolase K116M ChEMBL
  • Inhibitory activity against mutated recombinant Trypanosoma brucei aldolase K116M
  • Protection of inhibitory activity by DHAP against Trypanosoma brucei aldolase at 10 mM after 5 min ChEMBL
  • Protection of inhibitory activity by DHAP against Trypanosoma brucei aldolase at 10 mM after 5 min
  • Protection of inhibitory activity by DHAP against Trypanosoma brucei aldolase at 10 mM after 15 min ChEMBL
  • Protection of inhibitory activity by DHAP against Trypanosoma brucei aldolase at 10 mM after 15 min
  • Protection of inhibitory activity by FBP against Trypanosoma brucei aldolase at 1 mM after 5 min ChEMBL
  • Protection of inhibitory activity by FBP against Trypanosoma brucei aldolase at 1 mM after 5 min
  • Protection of inhibitory activity by FBP against Trypanosoma brucei aldolase at 1 mM after 15 min ChEMBL
  • Protection of inhibitory activity by FBP against Trypanosoma brucei aldolase at 1 mM after 15 min
  • Protection of inhibitory activity by FBP against Trypanosoma brucei aldolase at 10 mM after 5 min ChEMBL
  • Protection of inhibitory activity by FBP against Trypanosoma brucei aldolase at 10 mM after 5 min
  • Protection of inhibitory activity by FBP against Trypanosoma brucei aldolase at 10 mM after 15 min ChEMBL
  • Protection of inhibitory activity by FBP against Trypanosoma brucei aldolase at 10 mM after 15 min
  • Protection of inhibitory activity by HBP against Trypanosoma brucei aldolase at 1 mM after 5 min ChEMBL
  • Protection of inhibitory activity by HBP against Trypanosoma brucei aldolase at 1 mM after 5 min
  • Protection of inhibitory activity by HBP against Trypanosoma brucei aldolase at 1 mM after 15 min ChEMBL
  • Protection of inhibitory activity by HBP against Trypanosoma brucei aldolase at 1 mM after 15 min
  • Protection of inhibitory activity by HBP against Trypanosoma brucei aldolase at 0.1 mM after 5 min ChEMBL
  • Protection of inhibitory activity by HBP against Trypanosoma brucei aldolase at 0.1 mM after 5 min
  • Protection of inhibitory activity by HBP against Trypanosoma brucei aldolase at 0.1 mM after 15 min ChEMBL
  • Protection of inhibitory activity by HBP against Trypanosoma brucei aldolase at 0.1 mM after 15 min
  • Protection of inhibitory activity by NBP against Trypanosoma brucei aldolase at 1 mM after 5 min ChEMBL
  • Protection of inhibitory activity by NBP against Trypanosoma brucei aldolase at 1 mM after 5 min
  • Protection of inhibitory activity by NBP against Trypanosoma brucei aldolase at 1 mM after 15 min ChEMBL
  • Protection of inhibitory activity by NBP against Trypanosoma brucei aldolase at 1 mM after 15 min
  • Inhibition of Trypanosoma brucei class1 Aldolase ChEMBL
  • Inhibition of Trypanosoma brucei class1 Aldolase
  • Protection of inhibitory activity by DHAP against Trypanosoma brucei aldolase at 0.25 mM after 5 min ChEMBL
  • Protection of inhibitory activity by DHAP against Trypanosoma brucei aldolase at 0.25 mM after 5 min
  • Protection of inhibitory activity by DHAP against Trypanosoma brucei aldolase at 0.25 mM after 15 min ChEMBL
  • Protection of inhibitory activity by DHAP against Trypanosoma brucei aldolase at 0.25 mM after 15 min
  • Protection of inhibitory activity by DHAP against Trypanosoma brucei aldolase at 0.5 mM after 5 min ChEMBL
  • Protection of inhibitory activity by DHAP against Trypanosoma brucei aldolase at 0.5 mM after 5 min
  • Protection of inhibitory activity by DHAP against Trypanosoma brucei aldolase at 0.5 mM after 15 min ChEMBL
  • Protection of inhibitory activity by DHAP against Trypanosoma brucei aldolase at 0.5 mM after 15 min
  • Protection of inhibitory activity by DHAP against Trypanosoma brucei aldolase at 1 mM after 5 min ChEMBL
  • Protection of inhibitory activity by DHAP against Trypanosoma brucei aldolase at 1 mM after 5 min
  • Protection of inhibitory activity by DHAP against Trypanosoma brucei aldolase at 1 mM after 15 min ChEMBL
  • Protection of inhibitory activity by DHAP against Trypanosoma brucei aldolase at 1 mM after 15 min
  • Residual activity against Trypanosoma brucei class1 Aldolase at 0.5 mM after 5 min ChEMBL
  • Residual activity against Trypanosoma brucei class1 Aldolase at 0.5 mM after 5 min
  • Residual activity against Trypanosoma brucei class1 Aldolase at 0.5 mM after 15 min ChEMBL
  • Residual activity against Trypanosoma brucei class1 Aldolase at 0.5 mM after 15 min
  • Residual activity against Trypanosoma brucei class1 Aldolase at 0.02 mM after 5 min ChEMBL
  • Residual activity against Trypanosoma brucei class1 Aldolase at 0.02 mM after 5 min
  • Residual activity against Trypanosoma brucei class1 Aldolase at 0.02 mM after 15 min ChEMBL
  • Residual activity against Trypanosoma brucei class1 Aldolase at 0.02 mM after 15 min
  • Residual activity against Trypanosoma brucei class1 Aldolase at 100 uM after 15 min ChEMBL
  • Residual activity against Trypanosoma brucei class1 Aldolase at 100 uM after 15 min
  • ChEMBL
  • Inhibition of His-tagged recombinant Trypanosoma brucei fructose bis-phosphate aldolase expressed in Escherichia coli using FBP as substrate after 5 to 15 mins
  • ChEMBL
  • Competitive inhibition of His-tagged recombinant Trypanosoma brucei fructose bis-phosphate aldolase expressed in Escherichia coli by double-reciprocal plot analysis
  • BRENDA Assay
  • An enzyme with this EC number or name or sequence has been assayed in Trypanosoma brucei ( 3 )

Reagent availability

  • Reagent:
  • Target Type Source Notes
    Tb11.v5.0531 cloned gene BRENDA A gene with this EC number or name or sequence has been cloned from Trypanosoma brucei ( 1 )

Bibliographic References

43 literature references were collected for this gene.

If you have references for this gene, please enter them in a user comment (below) or Contact us.

User comments

No user comments are available for this gene. Log in to add comments, or register.

Enter your comment

User ()
Gene identifier Tb11.v5.0531 (Trypanosoma brucei), fructose-bisphosphate aldolase, glycosomal, putative
Title for this comment
Comment